![a group of people with luggage at an airport: UK travel update](https://r.search.yahoo.com/_ylt=AwrXnCL87UphECgADg3QtDMD;_ylu=Y29sbwNncTEEcG9zAzEEdnRpZAMEc2VjA3Ny/RV=2/RE=1632329341/RO=10/RU=https%3A%2F%2Fwww.msn.com%2Fen-in%2Fnews%2Fworld%2Fuk-changes-vaccine-policy-to-recognise-covishield-amid-row-over-discrimination-against-indians%2Far-AAOGNaW/RK=2/"default":"load":"default","w":"27","h":"15","src":"//img-s-msn-com.akamaized.net/tenant/amp/entityid/AAOGIKq.img?h=152&w=270&m=6&q=60&o=f&l=f")
UK journey replace
The UK has introduced modifications in its journey and quarantine guidelines and mentioned that the UK now recognises Covishield as a vaccine. This comes amid a rising row over UK not recognising the Covishield vaccine made in India.
Nevertheless, Indians who’ve taken the Covishield vaccine will nonetheless should stay in quarantine resulting from a ‘certification’ problem based on the UK authorities.
In its newest journey replace, the UK has mentioned that from October 4, one will qualify as absolutely vaccinated if they’re “vaccinated underneath an authorised vaccination programme within the UK, Europe, USA or UK vaccine programme abroad with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a related public well being physique in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan”.
It additional mentions, “Formulations of the 4 listed vaccines, comparable to AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as authorised vaccines.”
India on Tuesday warned of “reciprocal measures” if the UK doesn’t deal with its issues over the brand new journey guidelines referring to Covid-19 vaccine certification, calling the brand new coverage “discriminatory”.
Exterior Affairs Minister S Jaishankar additionally took up the difficulty of Covishield-vaccinated travellers being required to quarantine within the UK with newly-appointed British Overseas Secretary Elizabeth Truss at a gathering in New York on Tuesday.
“The essential problem is that here’s a vaccine, Covishield, which is a licensed product of the UK firm, manufactured in India of which we have now equipped 5 million doses to the UK on the request of the federal government of the UK,” mentioned Overseas Secretary Harsh Vardhan Shringla.
“We perceive that that is getting used underneath the nationwide well being system, and, subsequently, non-recognition of Covishield is a discriminatory coverage and does influence these of our residents travelling to the UK,” Shringla mentioned at a media briefing.
Watch Stay TV in English
Watch Stay TV in Hindi
